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Abstract
Introduction:  Several  methods  have  been  proposed  to  improve  operative  success  in  renal  hyper-
parathyroidism.
Objective:  To  evaluate  stereomicroscopy  in  parathyroid  tissue  selection  for  total  parathyroidec-
tomy with  autotransplantation  in  secondary  (SHPT)/tertiary  (THPT)  hyperparathyroidism.
Methods:  118  renal  patients  underwent  surgery  from  April  of  2000  to  October  2009.  They  were
divided  into  two  groups:  G1,  66  patients  operated  from  April  of  2000  to  May  of  2005,  with  tissue
selection based  on  macroscopic  observation;  G2,  52  patients  operated  from  March  of  2008  to
October 2009  with  stereomicroscopy  for  tissue  selection  searching  for  the  presence  of  adipose
cells. All  surgeries  were  performed  by  the  same  surgeon.  Patients  presented  SHPT  (dialysis
treatment)  or  THPT  (renal-grafted).  Follow-up  was  12--36  months.  Intra-operative  parathyroid
hormone  (PTH)  was  measured  in  100/118  (84.7%)  patients.
Results:  Data  are  presented  as  means.  G1  included  66  patients  (38  SHPT,  24  females/14  males;
40.0 years  of  age;  28  THPT,  14  females/14  males;  44  years  of  age).  G2  included  52  patients  (29
SHPT, 11  females/18  males;  50.7  years  of  age;  23  THPT,  13  females/10  males,  44.4  years  of
age). SHPT  patients  from  G2  presented  preoperative  serum  calcium  higher  than  those  of  SHPT
patients in  G1  (p  <  0.05),  suggesting  a  more  severe  disease.  Deﬁnitive  hypoparathyroidism  was
found in  seven  of  118  patients  (5.9%).  Graft-dependent  recurrence  occurred  in  four  patients,
two in  each  group.  All  occurred  in  dialysis  patients.
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Conclusion:  Stereomicroscopy  in  SHPT/THPT  surgical  treatment  may  be  a  useful  tool  to  stan-
dardize parathyroid  tissue  selection.
© 2014  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Published  by
Elsevier Editora  Ltda.  All  rights  reserved.
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Inﬂuência  do  critério  de  selec¸ão de  tecido  paratiroideano  com  ou  sem
estereomicroscopia  para  autoimplante  no  resultado  do  tratamento  cirúrgico  do
hiperparatiroidismo  associado  a  doenc¸a renal  crônica
Resumo
Introduc¸ão:  Diversos  métodos  têm  sido  propostos  com  intuito  de  melhorar  índices  de  sucesso
cirúrgico  no  tratamento  do  hiperparatiroidismo  associado  à  doenc¸a  renal  crônica  (DRC).
Objetivos:  Avaliar  uso  do  estereomicroscópio  na  selec¸ão  de  tecido  paratiroideano  na
paratiroidectomia  total  com  autoimplante  em  pacientes  com  DRC.
Métodos:  118  pacientes  DRC  operados  entre  04/2000-10/2009  foram  divididos  em:  G1-66
pacientes  operados  entre  04/2000-05/2005  cuja  selec¸ão  de  tecido  foi  realizada  por  método
convencional  (macroscopia);  G2-52  pacientes  operados  entre  03/2008-10/2009,  cuja  selec¸ão
de tecido  foi  realizada  com  uso  da  estereomicroscopia:  Leica-Stereomicroscope  (ampliﬁcac¸ão:
10×-80×). Pacientes  foram  ainda  categorizados  em  hiperparatiroidismo  secundário  (HPS)  ou
terciário  (HPT)  (HPS-diálise/HPT-transplantados  renais).  Seguimento  pós-operatório:  12-36
meses. PTH  intraoperatório  medido  100/118  pacientes  (84.7%).  Todos  pacientes  foram  operados
pelo mesmo  cirurgião.
Resultados:  Dados  em  média.  G1,  66  pacientes  (38  HPS,  24f/14m;  40  anos;  28  HPT,  14f/14m;
44 anos).  G2,  52  pacientes  (29  HPS,  11f/18m;  50,7  anos;  23  HPT,  13f/10m;  44,4  anos).  Pacientes
dialíticos  do  G2  apresentaram  cálcio  pré-operatório  maior  que  G1  (p  <  0,05),  sugerindo  doenc¸a
mais severa.  Hipoparatiroidismo  deﬁnitivo:  7/118  (5,9%)  pacientes:  G1,  4/66  (6%);  G2,  3/52
(5,7%). Recorrência  do  hiperparatiroidismo  no  autoimplante:  4  pacientes,  2  em  cada  grupo.
Todas foram  em  pacientes  em  diálise.
Conclusão:  Estereomicroscopia  no  tratamento  do  hiperparatiroidismo  associado  à  DRC  é  útil  na
padronizac¸ão da  técnica  de  selec¸ão  de  tecido  para  o  autoimplante.
© 2014  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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The  longer  survival  of  chronic  renal  patients  has  increased
the  incidence  of  symptomatic  hyperparathyroidism,  increas-
ing  the  need  of  surgical  procedure.1 The  best  surgical
approach  for  renal  hyperparathyroidism  is  still  debated  and
controversy  remains.  Relevant  questions  have  been  raised
regarding  treatment  election,  since  post-surgical  recurrence
and  the  risk  of  deﬁnitive  hypoparathyroidism  should  be
avoided.  Total  parathyroidectomy  with  parathyroid  tissue
autotransplantation  is  a  well-accepted  technique  for  the
management  of  these  patients.2--7 Since  recurrence  rates
of  8%8 to  20%9 and  up  to  76%10 have  been  reported  in
the  literature,  the  great  majority  graft-dependent,  tissue
selection  for  autotransplantation  has  been  presented  as
a  considerable  challenge.  Analysis  of  parathyroid  hyper-
plastic  tumors,  using  X-chromosome  inactivation,  have
demonstrated  that  monoclonal  transformation  is  a  frequent
occurrence  in  uremic  patients.11 In  fact,  the  great  major-
ity  (64%)  of  parathyroid  glands  with  generalized  hyperplasia
(non-nodular  component)  were  unequivocally  monoclonal,
as  demonstrated  by  Arnold  et  al.11 This  ﬁnding  imposes  a
difﬁcult  condition  in  parathyroid  tissue  selection  for  auto-
transplantation.
1
i
oIntraoperative  tissue  selection  of  parathyroid  fragments
sing  a  stereomagniﬁer  was  ﬁrst  described  by  Neyer  et  al.
n  2002.12 The  technique  can  differentiate  parathyroid  nor-
otropic  areas  by  the  presence  of  stromal  fat  cells  from
hose  that  are  disfunctional  and  hyperplastic  tissue  without
at  cells.12 Cells  from  these  lipid-containing  areas  present
n  optimal  in  vitro  suppression  of  parathyroid  hormone
PTH)  secretion  by  high  calcium  levels,13 indicating  a  normal
alcium  set-point  and  suggesting  the  eligibility  for  auto-
ransplantation.
The  aim  of  this  study  was  to  compare  stereomicroscopy
o  conventional  macroscopic  observation  in  parathyroid  tis-
ue  selection  using  a  historical  control,  in  order  to  provide
 standardized  procedure  for  renal  hyperparathyroidism
urgery.
atients and methods
atients18  renal  patients  underwent  total  parathyroidectomy  with
ntramuscular  presternal  autotransplantation7 from  April
f  2000  to  October  of  2009.  Patients  were  followed-up
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t  the  Renal  Osteodystrophy  Unit  in  this  institution  and
ere  referred  to  surgical  treatment  for  persistent  hyper-
alcemia  not  responsive  to  medical  interventions  and/or
ersistent  hyperphosphatemia  despite  the  continued  use
f  dietary  phosphorus  restriction  and  phosphate-binding
gents,  with  signs  and  symptoms  such  as  intractable  pru-
itus,  severe  bone  pain,  fractures  or  high  risk  of  fracture,
keletal  deformities,  extra  skeletal  calciﬁcations,  develop-
ent  of  calciphylaxis,  and  radiographic  evidences  of  renal
steodystrophy.
Patients  were  divided  into  two  groups:  group  1  (G1)
onsisted  of  66  patients  who  underwent  surgery  from  April
f  2000  to  May  of  2005,  and  parathyroid  tissue  selection
or  autotransplantation  was  performed  using  conventional
echnique  based  on  macroscopic  parathyroid  tissue  observa-
ion  by  a  single  experienced  surgeon;  group  2  (G2)  consisted
f  52  patients  who  underwent  surgery  from  March  of  2008
o  October  of  2009,  and  parathyroid  tissue  selection  for
utotransplantation  was  performed  by  the  same  surgeon  as
1,  based  on  stereomicroscopy  observation  using  a  Leica
tereo  Zoom  S8  APO  Stereomicroscope  (Leica  Microsys-
ems  GmbH  -- Wetzlar,  Germany),  with  magniﬁcation  of
0--80×.
Patients  were  classiﬁed  as  secondary  or  tertiary  hyper-
arathyroidism:  secondary  hyperparathyroidism  (SHPT)  was
haracterized  as  an  acquired  disorder  observed  in  end-
tage  renal  disease,  in  which  the  uremic  state  presents
 continuous  stimulus  to  the  parathyroid  glands.  The
HPT  group  included  patients  under  dialysis  treatment
ho  presented  severe  hyperparathyroidism  with  normal
r  high  serum  calcium  levels.  The  tertiary  hyper-
arathyroidism  (THPT)  group  comprised  renal  patients
ith  functioning  kidney  transplant  and  nonsuppressible
arathyroid  hyperplasia,  with  persistent  increased  PTH
evels  and  hypercalcemia.  Hypercalcemia  after  kidney
ransplantation  is  usually  due  to  hyperparathyroidism
hat  persists  from  the  preceding  chronic  kidney  disease
eriod.14
Surgical  cure  was  deﬁned  as  restoration  of  serum  cal-
ium  and  PTH  levels14 throughout  the  ﬁrst  six  months
fter  surgery.  Recurrence  was  deﬁned  when  high  lev-
ls  of  PTH  were  observed  throughout  late  post-operative
ollow-up  (one  year  after  surgical  procedure)  that  failed
o  respond  to  medical/pharmacological  management.
eﬁnitive  hypoparathyroidism  was  deﬁned  when  PTH
easurements  under  10  pg/mL  endured  one  year  after
arathyroidectomy,  with  normal  or  low  serum  calcium  levels
nder  vitamin  D  and  oral  calcium  supplementation.
Serum  ionized  calcium  (iCa),  phosphorus  (P),  alka-
ine  phosphatase  (AP),  and  intact  parathyroid  hormone
iPTH)  were  measured  before  parathyroidectomy  and
very  six  months  after  surgery  in  all  patients  from  both
roups.
Regarding  the  follow-up,  patients  from  both  groups  were
ollowed-up  after  surgery  on  a  regular  basis  in  the  Renal
steodystrophy  Unit,  and  patient  data  from  medical  reports
ere  available  for  this  study.  Patients  from  G1  underwent
urgery  from  2000  to  2005,  while  patients  from  G2  under-
ent  surgery  from  2008  to  2009.  Thus,  for  surgical  outcome
nalysis,  the  ﬁrst  36  months  were  the  period  selected  for
tudy  in  both  groups,  since  it  was  the  longest  period  avail-
ble  for  G2  patients.
I
p
oOhe  MN  et  al.
ethods
tudy  design
his  was  a comparative  study  using  a  historical  control,
valuating  stereomicroscopy  in  comparison  to  conventional
acroscopic  technique  in  parathyroid  tissue  selection  in  sur-
ical  treatment  of  renal  hyperparathyroidism.
This  investigation  was  approved  by  the  institutional
thics  committee  (approval  No.  CEP  0234/06)  and  patients
igned  an  informed  consent  prior  to  their  inclusion  in  the
tudy.
urgical  strategy
ilateral  cervical  exploration  with  at  least  four-gland
xcision  conﬁrmed  by  frozen  section  examination  and/or
ntra-operative  PTH  (IO-PTH)  measurement  was  performed
n  all  118  patients  (IO-PTH  available  in  100  patients).
Removed  parathyroid  glands  were  carefully  examined
n  order  to  select  a  parathyroid  area  (non-nodular  region)
or  implant  and  cryopreservation.  The  selected  parathy-
oid  fragment  was  gently  diced  into  small  pieces  measuring
pproximately  2.0  mm3.  Approximately  30  parathyroid  frag-
ents  were  implanted  in  presternal  musculature  over  a
ingle  area  of  1.5  cm  in  length.7 Another  30  fragments  were
elected  for  cryopreservation.  The  reasons  for  changing  the
rafted  area  from  the  forearm  to  the  presternal  muscu-
ature  are  related  to  some  potential  advantages.  First,  it
reserves  the  forearm  for  arterio-venousus-ﬁstula  dialysis  if
eeded.  Second,  the  presternal  region  is  close  to  the  cervi-
otomy,  exposing  the  same  surgical  area.  Third,  it  allows  for
n  easier  graft-removal  in  case  of  graft-dependent  recur-
ence;  the  sternal  bone  presents  a  posterior  boundary  for
he  grafted  tissue,  enabling  a  graft  removal  under  local
nestesia.7 All  surgeries  were  performed  by  the  same  sur-
eon  in  both  groups  G1  and  G2.
rotocol  for  intraoperative  tissue  selection
roup  1  --  Conventional  technique:  tissue  selection  for
utotransplantation  based  on  macroscopic  parathyroid
bservation  was  performed  in  66  patients.  Nodular  parathy-
oid  regions  were  avoided,  while  hyperplasic  non-nodular
arathyroid  areas  were  considered  eligible  for  autotrans-
lantation  (Fig.  1).
Group  2  --  Stereomicroscopy:  parathyroid  tissue  selection
sing  Leica  Stereo  Zoom  S8  APO  Stereomicroscope  (Leica
icrosystems  GmbH  --  Wetzlar,  Germany)  with  apochro-
atic  8:1  zoom,  10--80× magniﬁcation,  was  performed  in
2  patients.  Resected  parathyroid  glands  were  ﬁrst  observed
acroscopically,  and  stereomicroscopic  analysis  was  per-
ormed  thereafter,  searching  for  the  presence  of  stromal  fat
ells  in  the  parathyroid  glands  (Fig.  2, arrows).
iochemistryO-PTH  was  performed  to  conﬁrm  total  removal  of  the
arathyroid  glands,  in  order  to  avoid  overlooking  remaining
r  supernumerary  hyperfunctioning  glands.  IO-PTH  was
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Figure  1  Macroscopic  parathyroid  tissue  observation:  A,  nodular  parathyroid  regions  not  eligible  for  autotransplantation;  B,
hyperplasic non-nodular  parathyroid  area  eligible  for  autotransplantation.Figure  2  Stromal  fat  cells  (arrows)  in  resected  parathyroid  glands.
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Table  1  Pre-operative  data  and  laboratory  ﬁndings.
G1  (n  =  66)  G2  (n  =  52)
SHPT  THPT  SHPT  THPT
n  38  28  29  23
Age 40.0  (14--58)  44.0  (24--62)  50.7  (26--74)  44.4  (28--63)
Female/male  24/14  14/14  11/18  13/10
Years on  dialysis 7.7  (0.6--16) 6.5  (2--20) 7.9  (3--25) 6.4  (0.8--13)
Years of  renal  graft -- 2.8  (0.5--7) -- 3.3  (0.4--10)
Pre-op iCa 1.36a (1.19--1.83) 1.59  (1.42--1.77) 1.41a (1.21--1.59) 1.58  (1.41--1.90)
Pre-op iPTH  1618.7  (298--2500)  442.2  (109--1758)  1810.2  (561--3500)  465.8  (181--2237)
Reference values: iCa = 1.20--1.40 mmol/L; iPTH = 10--65 pg/mL.
Data expressed as mean and range.
SHPT, secondary hyperparathyroidism; THPT, tertiary hyperparathyroidism; iCa, serum ionized calcium; iPTH, intact parathyroid hor-
mone.
a t-test: p < 0.05.
Table  2  Post-operative  mean  iCa  and  iPTH  in  cured  patients  in  G1-group  (conventional).
SHPT  THPT
iCa  iPTH  iCa  iPTH
12  months  (n  =  34)  1.17  79.8  (n  =  25)  1.25  58.4
24 months  (n  =  29)  1.22  86.0  (n  =  19)  1.22  64.7
36 months  (n  =  21)  1.19  83.0  (n  =  16)  1.22  78.5
Reference values: iCa = 1.20--1.40 mmol/L; iPTH = 10--65 pg/mL.
Data expressed as means.
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mone.
easured  using  the  Elecsys  PTH  Immunoassay  (Elecsys  1010
ystem;  Roche  --  Mannheim,  Germany)  and  was  available
or  100  patients  (84.7%).  The  time  required  to  perform  the
ssay  is  nine  minutes  and  reference  values  are  10--70  pg/mL.
eripheral  venous  blood  sample  (4.0  mL)  was  obtained
mmediately  after  induction  of  anesthesia  and  20  min  after
emoval  of  all  parathyroid  glands.15--17
Total  serum  calcium,  phosphorus,  total  alkaline  phos-
hatase,  and  creatinine  were  measured  by  means  of
tandard  automatic  assays  (Hitachi  912  --  Roche).  Serum
onized  calcium  was  measured  by  using  an  ion-speciﬁc
lectrode  (AVL  9180  Electrolyte  Analyzer  --  Roswell,
eorgia,  United  States).  Parathyroid  hormone  in  ambu-
atory  conditions  was  measured  by  immunometric  assay
T
d
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Table  3  Post-operative  mean  iCa  and  iPTH  in  cured  patients  in  G
SHPT  
iCa  iPT
12  months  (n  =  26)  1.15  6
24 months  (n  =  18)  1.09  11
36 months  (n  =  13)  1.13  12
Reference values: iCa = 1.20--1.40 mmol/L; iPTH = 10--65 pg/mL.
Data expressed as mean.
SHPT, secondary hyperparathyroidism; THPT, tertiary hyperparathyroi
mone.dism; iCa, serum ionized calcium; iPTH, intact parathyroid hor-
Immulite;  Siemens  --  São  Paulo,  Brazil:  reference  values
0--65  pg/mL).
All  removed  parathyroid  tissue  underwent  complete
istopathology  analysis.
esults
re-operative  data  and  laboratory  ﬁndings  are  depicted  in
able  1.
Mean  post-operative  iPTH  and  iCa  serum  measurements
uring  the  follow-up  of  cured  patients  in  both  groups  are
hown  in  Tables  2  and  3.
2-group  (stereomicroscopy).
THPT
H  iCa  iPTH
1.3  (n  =  21)  1.20  60.8
3.2  (n  =  14)  1.18  65.0
5.4  (n  =  9)  1.22  80.1
dism; iCa, serum ionized calcium; iPTH, intact parathyroid hor-
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Table  4  Graft-dependent  recurrence  in  patients  from  G1  (2/66)  --  conventional  technique,  and  from  G2  (2/52)  --
stereomicroscopy.
12  months  24  months  36  months
iCa  iPTH  iCa  iPTH  iCa  iPTH
Patient  1  (G1)  1.46  13  --  --  1.29  1165
Patient 2  (G1)  0.90  22  1.29  104  1.56  168
Patient 3  (G2) 1.49 70  1.40  717  1.49  940
Patient 4  (G2) 1.21 224  0.97  1259  --  --
Reference values: iCa = 1.20--1.40 mmoL/L; iPTH = 10--65 pg/mL.
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tiCa, serum ionized calcium; iPTH, intact parathyroid hormone.
Persistent  hyperparathyroidism  due  to  supernumerary
parathyroid  glands  not  recognized  during  surgical  procedure
was  observed  in  two  patients,  one  from  each  group;  those
patients  were  excluded  from  the  study.
Deﬁnitive  hypoparathyroidism  was  observed  in  7/118
(5.9%)  patients,  4/66  (6%)  in  G1,  and  3/52  (5.7%)  in  G2.
Graft-dependent  recurrence  was  observed  in  4/118
(3.3%)  patients,  two  in  each  group  (G1,  2/66;  3.0%  and
G2,  2/52;  3.8%)  (Table  4).  All  graft-dependent  recurrences
were  observed  in  dialysis  patients.  None  occurred  in  kidney-
grafted  patients.
Discussion
Surgery  for  renal  hyperparathyroidism  is  performed  in  Brazil
in  relatively  few  medical  centers,  sometimes  leading  to  long
waiting  times  and,  consequently,  to  worse  clinical  condi-
tions  at  the  time  of  surgery.  Throughout  the  years,  the
authors  have  observed  a  worsening  in  medical  conditions
among  renal  patients  at  the  time  of  surgery,  when  com-
paring  patients  from  G1  (surgeries  performed  from  04/2000
to  05/2005)  to  G2  (surgeries  performed  from  03/2008  to
10/2009).  As  observed  in  SHPT  patients  from  G2,  serum  cal-
cium  levels  were  higher  than  those  seen  in  SHPT  patients
from  G1  (t-test;  p  <  0.05).  This  ﬁnding  is  in  agreement  with
patients  with  a  more  severe  disease  and,  moreover,  these
are  indicators  that  patients  in  G2  underwent  surgery  in
a  worse  condition.  Thus,  the  apparently  similar  surgical
results  in  graft-dependent  recurrence  observed  between  G1
and  G2  (two  recurrences  in  each  group)  could  be  assessed  as
a  positive  outcome  for  stereomicroscopy.  The  more  severe
disease  observed  in  G2  may  be  the  explanation  for  the
ﬁnding  of  a  similar  recurrence  in  both  groups.  Since  the
macroscopic  examination  protocol  used  in  G1  was  performed
by  the  same  surgeon  that  also  supervised  the  stereomi-
croscopy  in  G2,  a  fair  comparison  can  be  performed.
From  the  118  overall  patients,  graft-dependent  recur-
rence  was  observed  only  in  four  (3.3%).  This  can  be
considered  a  low  graft-dependent  recurrence  rate  com-
pared  to  literature  data.18--20 Considering  the  gravity  of
the  illness  observed  in  these  patients,  the  experience  of
the  surgeon  probably  contributed  to  such  a  positive  out-
come.
The  clearly  abnormal  macroscopic  ﬁndings  observed
in  removed  parathyroid  indicate  the  severity  of  the  ill-
ness  and  impose  an  especially  difﬁcult  challenge  in  tissue
s
i
A
telection.  The  effort  for  ﬁnding  eligible  areas  for  auto-
ransplantation  among  abnormal  parathyroid  glands  makes
tereomicroscopy  an  interesting  tool  for  its  standardization.
he  search  for  stromal  fat  cells  as  previously  described  by
eyer  et  al.12 may  provide  a  reproducible  technique  for
issue  selection  in  attempts  to  reach  low  graft-dependent
ecurrences  rates,  even  for  surgeons  not  so  experienced  in
arathyroid  surgeries.
Another  important  observation  is  that  all  graft-
ependent  recurrences  were  in  dialysis  patients.  None
ccurred  in  kidney-grafted  patients.  It  is  probable  that
he  continuous  exposure  of  the  grafted  parathyroid  tissue
o  uremic  environment  may  be  the  main  driver  for  tumor
ecurrence  in  patients  under  long-term  dialysis  treatment,
ndependent  of  the  surgical  technique  employed.
Post-operative  PTH  measurements  during  the  follow-up
f  cured  patients  were  similar  in  G1  and  G2,  as  were  deﬁni-
ive  hypoparathyroidism  rates.
As  mentioned  above,  persistent  hyperparathyroidism  due
o  supernumerary  parathyroid  glands  not  recognized  dur-
ng  surgical  procedure  was  observed  in  two  patients,  one
n  each  group  and  those  patients  were  excluded  from
he  study.  Occurrence  of  supernumerary  and/or  ectopic
arathyroid  glands  is  more  frequent  among  chronic  kid-
ey  failure  patients,21 and  this  presents  an  important  and
dditional  challenge  in  surgical  treatment  of  renal  hyper-
arathyroidism.
Limitations  are  related  to  the  heterogeneous  character-
stics  of  renal  patients  enrolled  in  this  study,  with  their
articular  clinical  and  laboratory  ﬁndings,  and  considering
hem  as  a  group  presents  a  real  challenge,  especially  when
 historical  control  is  used.  Another  limitation  is  related  to
he  severity  of  these  patients:  the  marked  illness  and  long-
asting  renal  condition  makes  them  a  special  group,  whose
utcome  would  not  be  expected  in  ordinary  patients  with
hronic  renal  disease.  In  addition,  levels  of  25-OH  vitamin  D
ere  not  available  in  this  study.
onclusion
tereomicroscopy  in  renal  hyperparathyroidism  surgical
reatment  may  provide  a  standardized  parathyroid  tissue
election  for  autotransplantation,  and  is  potentially  helpful
n  obtaining  a  low  incidence  of  graft-dependent  recurrence.
dditional  controlled  and  randomized  studies  are  necessary
o  conﬁrm  these  results.
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